Treatment of respiratory disease in horses where it is considered that airway obstruction due to bronchospasm and/or accumulation of mucus is a contributing factor, and improved mucociliary clearance is desirable. To be used alone or as adjuvant therapy.
Active(s): Methyl parahydroxybenzoate (E218), Propyl parahydroxybenzoate, Carbomer 974P, Sucrose, Macrogol 400, Glycerol (85%), Ethanol (96%), Sodium hydroxide, Water, purified
Pack sizes: 355 ml
For the sedation and slight analgesia of horses and cattle; to facilitate physical examinations and treatments, such as minor surgical interventions.
Active(s): Detomidine hydrochloride
Pack sizes: 5 ml, 10 ml, 20 ml
For the treatment of infections in horses caused by micro-organisms susceptible to the combination of trimethoprim and sulfadiazine, such as infections of the upper respiratory tract, the urogenital system and wound infections.
Active(s): Sulfadiazine Trimethoprim
Treatment of infections in horses caused by bacteria sensitive to the combination of
trimethoprim and sulfadiazine, particularly:
Respiratory tract infections associated with Streptococcus spp. and Staphylococcus aureus;
Gastrointestinal infections associated with E. coli;
Urogenital infections associated with beta-hemolytic streptococci;
Wound infections and open or drained abscesses associated with Streptococcus spp. and Staphylococcus aureus.
Pack sizes: 45 g
Indicated in the treatment of musculoskeletal disorders in horses and ponies where the anti-inflammatory and analgesic properties of phenylbutazone can offer relief, for example, in lameness associated with osteoarthritic conditions, acute and chronic laminitis, bursitis and carpitis.
Pack sizes: 6 dose
For the treatment of musculoskeletal disorders in horses and ponies where the anti-inflammatory and analgesic properties of phenylbutazone can offer relief. Examples of conditions normally considered suitable for treatment with phenylbutazone include lameness associated with osteoarthritic conditions, acute and chronic laminitis, bursitis and carpitis, and in the reduction of post-surgical soft tissue reaction.
Pack sizes: 100 x 1 g
For active immunization of horses to reduce clinical signs and to reduce virus excretion during respiratory disease caused by equine herpesvirus type 1 (EHV-1) infections.
Onset of immunity: 2 weeks after the second vaccine injection Duration of immunity has only been demonstrated after the administration of three vaccine injections (see section 4.9): 6 months after the 3rd vaccine injection.
For active immunisation of pregnant mares to reduce the occurrence of abortions caused by equine herpesvirus type 1 (EHV-1) infections.
Onset immunity: 3 weeks after the 3rd vaccine injection during gestation Duration of immunity: until the end of pregnancy.
Active(s): Inactivated equine herpes virus type 1, (Bio 82: EHV-1) Min. 2.1 log10 VNI1 1 Virus neutralization index determined in serum of hamsters
Pack sizes: 10 x 1 ml
For infiltration, nerve block, intra-articular and epidural anaesthesia in horses.
Active(s): Mepivacaine hydrochloride
Pack sizes: 6 x 10 ml
For use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs in cattle. For use in diarrhoea in combination with oral re-hydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle. For adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy. For the relief of post-operative pain following dehorning in calves.
For use in non-infectious locomotor disorders to reduce the symptoms of lameness and inflammation. For adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritisagalactia syndrome) with appropriate antibiotic therapy.
For use in the alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders. For the relief of pain associated with equine colic.
Pack sizes: 100 ml
Infestations with adult stages of roundworm, particularly ascarids (Parascaris equorum), small strongyles (Cyathostomum spp., Triodontophorus spp.) and large strongyles (Strongylus edentatus, Strongylus equinus, Strongylus vulgaris), seatworm/pinworm (Oxyuris equi) and tapeworm (Anoplocephala perfoliata) in horses, ponies and foals. The efficacy towards Anoplocaphala perfoliata is variable.
Active(s): Pyrantel embonate
Pack sizes: 30.33 g
In horses, cattle, pigs, dogs and cats:
Treatment of inflammatory or allergic conditions.
Treatment of primary ketosis (acetonaemia).
Induction of parturition
Treatment of arthritis, bursitis or tenosynovitis.
Pack sizes: 100 ml
Sedative to facilitate handling, examination, minor surgical interventions and minor procedures. For premedication prior to administration of injectable or inhalation anaesthetics. Romifidine can also be used with synthetic opiates (e.g. butorphanol) to provide deeper sedation/analgesia.
Active(s): Romifidine hydrochloride
Pack sizes: 20 ml
The product is indicated for euthanasia in dogs, cats, horses and cattle.
50 ml bottle of Somulose
50 ml syringe
16 gauge sterile cannula
Active(s): Secobarbital sodium (quinalbarbitone sodium), cinchocaine hydrochloride
Pack sizes: 50 ml
Horses, cattle, pigs, dogs: treatment of smooth muscle spasms and pain associated with underlying disorders of the gastro-intestinal tract, urogenital system and bile excretory organs.
Horses only: Spasmodic colics.
Cattle, pigs, dogs: Supportive therapy for acute diarrhoea and gastroenteritis.
Active(s): Metamizole sodium monohydrate
Pack sizes: 100 ml
In all target species:
- Treatment of superficial wound infections caused by micro-organisms sensitive to thiamphenicol.
Pack sizes: 150 ml
This product is administered by intravenous infusion for the treatment of dehydration in cattle, horses, dogs and cats. It may be used to correct hypovolaemia resulting from shock or gastrointestinal disease (especially where metabolic alkalosis is present, e.g. in cases of sustained vomiting or abomasal disorders in cattle). It may be administered to meet normal fluid and electrolyte requirements when fluids cannot be given orally.
Active(s): Sodium chloride 9mg
Pack sizes: 20 x 500 ml, 50 x 100 ml, 4 x 2 L, 10 x 1 L
This product is administered by intravenous infusion for the treatment of dehydration and metabolic acidosis in cattle, horses, dogs and cats. It may be used to correct volume depletion (hypovolaemia) resulting from gastrointestinal disease or shock.
Active(s): Sodium lactate 0.317% w/v, sodium chloride 0.600% w/v, potassium chloride 0.040% w/v, calcium chloride dihydrate 0.027% w/v
Pack sizes: 20 x 250 ml, 20 x 500 ml, 2 x 5 L, 4 x 3 L, 10 x 1 L